Bringing new medicinal products to patients worldwide and ensuring uninterrupted supply of high-quality medicines can involve complex and lengthy processes…
In this session, regulatory leaders from the EMA, Health Canada, PMDA, Health Canada, and international health authorities including WHO will delve into the challenges hindering the path to regulatory reliance and approval of advanced technologies…